Berkshire Hathaway (BRK.B)
(Delayed Data from NYSE)
$467.70 USD
-0.40 (-0.09%)
Updated Nov 14, 2024 04:01 PM ET
After-Market: $467.22 -0.48 (-0.10%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$467.70 USD
-0.40 (-0.09%)
Updated Nov 14, 2024 04:01 PM ET
After-Market: $467.22 -0.48 (-0.10%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Zacks News
Berkshire Hathaway B (BRK.B) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Berkshire Hathaway B (BRK.B) closed at $265.53 in the latest trading session, marking a +0.46% move from the prior day.
Why Should You Stay Invested in Selective Insurance (SIGI)
by Zacks Equity Research
Solid renewal pricing, increase in exposure, higher income earned on fixed income securities and prudent capital deployment well poise Selective Insurance (SIGI) for growth.
Should You Add NMI Holdings (NMIH) Stock to Your Kitty Now?
by Zacks Equity Research
An improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program, solid capital position, effective capital deployment well poise NMI Holdings (NMIH) for growth.
Should You Invest in the Fidelity MSCI Financials Index ETF (FNCL)?
by Zacks Equity Research
Sector ETF report for FNCL
Is Trending Stock Berkshire Hathaway Inc. (BRK.B) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Berkshire Hathaway B (BRK.B) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
W. R. Berkley (WRB) Gains 21% YTD: Can It Retain the Momentum?
by Zacks Equity Research
Solid insurance business, strong international business and sturdy financial position continue to drive W. R. Berkley (WRB).
AXIS Capital (AXS) Rallies 17% in a Year: More Upside Left?
by Zacks Equity Research
The repositioning of portfolio and markets offering profitable growth, lower volatility, strong market presence, better pricing, margin expansion and effective capital deployment continue to drive AXIS Capital (AXS).
Chubb (CB) Gains 9% in a Year: More Room for Upside Left?
by Zacks Equity Research
A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position continue to drive Chubb (CB).
Should You Invest in the Financial Select Sector SPDR ETF (XLF)?
by Zacks Equity Research
Sector ETF report for XLF
The Zacks Analyst Blog Highlights Berkshire Hathaway, Tencent and HSBC
by Zacks Equity Research
Berkshire Hathaway, Tencent and HSBC are included in this Analyst Blog.
Berkshire Hathaway B (BRK.B) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Berkshire Hathaway B (BRK.B) closed the most recent trading day at $278.95, moving +1.51% from the previous trading session.
The Fed Meeting: Global Week Ahead
by John Blank
What matters? In this order: The Fed, the Fed and the Fed. What matters most is the projected path of 2023 Fed Funds rates.
Here's Why You Should Add Everest Re (RE) to Your Kitty
by Zacks Equity Research
Segmental strength, a solid capital position and favorable growth estimates make Everest Re (RE) stock worth adding to one's portfolio.
Arthur J. Gallagher (AJG) Gains 23% in a Year: More Upside Left?
by Zacks Equity Research
Strong performing Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities, effective capital deployment and upbeat guidance continue to drive Arthur J. Gallagher (AJG).
The Zacks Analyst Blog Highlights W. R. Berkley, Unum Group, Arch Capital Group, Everest Re Group and Berkshire Hathaway
by Zacks Equity Research
W. R. Berkley, Unum Group, Arch Capital Group, Everest Re Group and Berkshire Hathaway are included in this Analyst Blog.
Arch Capital (ACGL) Rallies 20% in a Year: More Upside Left?
by Zacks Equity Research
New business opportunities, rate increases, growth in existing accounts and solid capital position continue to drive Arch Capital (ACGL).
Progressives (PGR) August Earnings Rise on Higher Revenues
by Zacks Equity Research
Progressive's (PGR) August earnings reflect higher revenues coupled with lower expenses.
Top 5 Insurance Stocks to Play a Higher Interest Rate Regime
by Nalak Das
We have narrowed our search to five insurers that have strong growth potential for the rest of 2022. These are: BRK.B, WRB, UNM, ACGL and RE.
Should You Invest in the Vanguard Financials ETF (VFH)?
by Zacks Equity Research
Sector ETF report for VFH
Should Vanguard Russell 1000 Value ETF (VONV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VONV
Why You Should Stay Invested in First American (FAF) Stock
by Zacks Equity Research
First American (FAF) remains well poised to capitalize on the increased demand among millennials for first-time home purchases.
Should Vanguard S&P 500 Value ETF (VOOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOOV
Berkshire Hathaway B (BRK.B) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Berkshire Hathaway B (BRK.B) closed the most recent trading day at $288.51, moving +0.96% from the previous trading session.
Is Most-Watched Stock Berkshire Hathaway Inc. (BRK.B) Worth Betting on Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Berkshire Hathaway B (BRK.B). This makes it worthwhile to examine what the stock has in store.
The Zacks Analyst Blog Highlights Microsoft, CVS Health, Lockheed Martin, Berkshire Hathaway and Mitsubishi UFJ Financial Group
by Zacks Equity Research
Microsoft, CVS Health, Lockheed Martin, Berkshire Hathaway, and Mitsubishi UFJ Financial Group are part of The Zacks top Analyst Blog.